- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: hypertensive type 2 diabetes patients
Total 180209 results
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Jeil Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes MellitusKorea, Republic of
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
BayerActive, not recruiting
-
Universiti Sains MalaysiaCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingType 2 Diabetes MellitusChina
-
Centre Hospitalier Sud FrancilienCompleted
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusChina
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Rush University Medical CenterWithdrawn
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Samsung Medical CenterNovartisCompletedType 2 Diabetes MellitusKorea, Republic of
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
AstraZeneca TurkeyOptimum Contract Research Organization, TurkeyCompletedType 2 Diabetes MellitusTurkey
-
Cheng Qing-fengUnknownType 2 Diabetes Mellitus
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownType 2 Diabetes MellitusChina
-
Novartis PharmaceuticalsCompletedType-2 Diabetes MellitusHong Kong
-
National University of SingaporeNational University Hospital, SingaporeUnknown
-
Lawson Health Research InstituteAstraZenecaCompleted
-
NovartisCompleted
-
Dong-A ST Co., Ltd.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityUnknown
-
University of ArizonaUnknownType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCTerminatedType 2 Diabetes Mellitus
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
-
Valeritas, Inc.Integrated Medical DevelopmentCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Germany, Greece, Denmark, France
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusIreland, United Kingdom
-
AstraZenecaEli Lilly and CompanyCompleted
-
Hospital Universitario Central de AsturiasSanofiTerminated
-
Endocrine Research SocietyCompletedType 2 Diabetes MellitusCanada
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusPoland, United Kingdom, Germany, Romania, Hungary, Denmark, Lithuania
-
SanofiCompletedType 2 Diabetes MellitusUkraine
-
SanofiCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Tehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt, United Kingdom, Turkey, Lebanon, Russian Federation, Tunisia, Malaysia, Germany, Spain, Saudi Arabia, Denmark, Indonesia, Jordan, Kuwait, Singapore, United Arab Emirates
-
SanofiCompleted
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
Tehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Karolinska InstitutetThe Swedish Research Council; Actelion; Swedish Heart Lung FoundationCompletedType 2 Diabetes MellitusSweden
-
SanofiCompletedType 2 Diabetes MellitusFrance, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States